Abilify (aripiprazole) is a prescription atypical (second-generation) antipsychotic that treats depression, schizophrenia, and bipolar disorder. It also treats irritability related to autism and ...

Abilify is not a controlled substance. It’s an atypical antipsychotic drug. Abilify has some high risk side effects. It also carries boxed warnings, the most serious warnings from the Food and Drug ...

Bristol-Myers Squibb Co. will pay $19.5 million to settle allegations that the London-based drugmaker improperly marketed and promoted its anti-psychotic drug Abilify, reports Reuters. The drugmaker ...

Otsuka Pharmaceuticals and Proteus Digital Health’s sensor-carrying pill Abilify MyCite is on its way to US patients thanks to a new collaboration agreement between Otsuka and Magellan Health.